[go: up one dir, main page]

GB201421900D0 - Vasculature Targeting - Google Patents

Vasculature Targeting

Info

Publication number
GB201421900D0
GB201421900D0 GBGB1421900.0A GB201421900A GB201421900D0 GB 201421900 D0 GB201421900 D0 GB 201421900D0 GB 201421900 A GB201421900 A GB 201421900A GB 201421900 D0 GB201421900 D0 GB 201421900D0
Authority
GB
United Kingdom
Prior art keywords
vasculature targeting
vasculature
targeting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1421900.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Priority to GBGB1421900.0A priority Critical patent/GB201421900D0/en
Publication of GB201421900D0 publication Critical patent/GB201421900D0/en
Priority to PCT/GB2015/053771 priority patent/WO2016092301A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/12—Applications; Uses in screening processes in functional genomics, i.e. for the determination of gene function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1421900.0A 2014-12-09 2014-12-09 Vasculature Targeting Ceased GB201421900D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1421900.0A GB201421900D0 (en) 2014-12-09 2014-12-09 Vasculature Targeting
PCT/GB2015/053771 WO2016092301A1 (en) 2014-12-09 2015-12-09 Vascular targeting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1421900.0A GB201421900D0 (en) 2014-12-09 2014-12-09 Vasculature Targeting

Publications (1)

Publication Number Publication Date
GB201421900D0 true GB201421900D0 (en) 2015-01-21

Family

ID=52425706

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1421900.0A Ceased GB201421900D0 (en) 2014-12-09 2014-12-09 Vasculature Targeting

Country Status (2)

Country Link
GB (1) GB201421900D0 (en)
WO (1) WO2016092301A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113862218B (en) * 2021-10-12 2024-06-25 广州医科大学附属第一医院（广州呼吸中心） A tumor-related vascular pericyte subpopulation and its preparation method and application
WO2025024284A1 (en) * 2023-07-21 2025-01-30 The Board Of Regents Of The University Of Texas System Monoclonal antibodies against pcdh7 for lung cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006009915A2 (en) * 2004-06-17 2006-01-26 The Trustees Of Columbia University In The City Of New York Use of genetically- and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer
WO2011124669A1 (en) * 2010-04-08 2011-10-13 Institut Gustave Roussy Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family

Also Published As

Publication number Publication date
WO2016092301A1 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
IL304663A (en) Combination
ZA201604680B (en) Aerosol-forming member
ZA201604697B (en) Aerosol-forming member
GB201520799D0 (en) None
PL3099189T3 (en) Aerosol-forming member
GB201413019D0 (en) Beyond 1B
IL247073A0 (en) Combination
PT3092043T (en) Toy
GB201413050D0 (en) None
GB201516266D0 (en) None
GB201516146D0 (en) None
GB201418637D0 (en) Laser
GB201419091D0 (en) Formulations
GB201419261D0 (en) Formulations
LT3237349T (en) Improved biobinder
EP3096691C0 (en) Catheter
GB201421900D0 (en) Vasculature Targeting
GB2523854B (en) Circuitry
GB2522700B (en) Amplifier
GB201409138D0 (en) None
GB201604697D0 (en) None
GB201604696D0 (en) None
AU2014902459A0 (en) Targeting agents
GB201418645D0 (en) Shelf
PH32014001139S1 (en) Hi-stacker cart

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)